ALLIED CORP - ALID STOCK NEWS

Allied Corp (OTCQB: ALID), a Colombian cannabis cultivator, announces a joint venture with Blueberries Medical Corp (OTC: BBRRF), a leading extraction company. This partnership aims to produce psychoactive and non-psychoactive cannabis derivatives, integrating Allied’s high-quality flower production with Blueberries’ advanced extraction capabilities. The collaboration is expected to enhance sales efforts and expand Allied's global presence, with partners across five continents. CEO Calum Hughes expressed excitement for the venture, indicating potential growth and product diversification in international markets.

Allied Corp (OTCQB: ALID) has successfully completed a sale of 200kgs of cannabis flower, enhancing its established supply chain. This follows prior shipments totaling 272kgs, 200kgs, 1728kgs, and 3425kgs, underscoring Allied's significant international market engagement across five continents. CEO Calum Hughes praised the sales team's efforts amidst challenging market conditions. The company aims to leverage its Colombian operations for research and development, positioning itself as a leader in the medical cannabis sector.

Allied Corp (OTCQB: ALID) announced the completion of its first two THC cannabis harvests in Colombia, with preparations for sale and export underway. The first harvest consisted of 2,200 plants, while the second included 6,100 plants, contributing to a scalable supply chain. The laboratory analysis indicated a total cannabinoid percentage of 28.13%. Allied aims to leverage its Colombian operations for high-quality THC flower in international markets, while emphasizing its commitment to sustainability and carbon neutrality.

Allied Corp. has achieved a significant milestone by shipping 3,425 kgs of medicinal cannabis from Colombia, marking the largest known cannabis export globally. Since June 2022, the company has successfully completed four shipments: 272 kgs in June, 200 kgs in July, and 1,728 kgs in August. This development showcases the establishment of a robust supply chain and positions Allied as a key player in the international cannabis market. With plans for a THC harvest in September 2022, Allied is set to strengthen its operations further.

Allied Corp (OTCQB: ALID) announced it has received ANVISA approval for importing medical products into Brazil, following a thorough regulatory review. This approval follows the signing of a forward purchase agreement in April 2022 and successful initial shipment in June 2022. With this approval, Allied aims to expand its market presence in Brazil, particularly in the populous Sao Paulo area, which serves over 22 million residents. Allied plans to partner with major medical groups to meet patient needs in this growing market.

Allied Corp has made history by being the first company to successfully export commercial cannabis flower from Colombia. A total of 7100kgs of Colombian-grown cannabis has received export approval, with an initial shipment of 1728kgs sent to Switzerland. Weekly shipments of 1500kgs are planned until the total quantity is reached. The company attributes this achievement to its team's regulatory expertise and production capabilities. Additionally, Allied plans to market over 15,000 THC plants by September 2022, expanding its presence in the international cannabis market.

Allied Corp (OTCQB: ALID) successfully completed its second shipment of commercial dried cannabis from Colombia, totaling 1,000 kg. The shipment, which included 272 kg on July 14, 2022, is destined for the medical market in Australia via Zurich, Switzerland. Following Colombia's April 2022 legislation allowing cannabis exports, Allied was the first company to ship cannabis internationally and is now replicating these efforts. The company has additional orders, including 7,100 kg for a Swiss client and recurring monthly orders for other regions, demonstrating its growing international presence.

Allied Corp (OTCQB: ALID) has successfully made its first shipment of commercial dried cannabis from Colombia to international markets. Authorization for this shipment came after Colombia enacted legislation in April 2022 allowing the legal export of cannabis. The initial shipment of 200kg represents part of a monthly supply contract for 500kgs. The strain has 18% CBD and less than 0.3% THC, compliant with U.S. regulations. Allied has further export approvals for various future shipments, highlighting its potential to expand its international market presence.

Allied Corp (OTCQB: ALID) has signed a forward purchase agreement with a Sao Paulo-based distributor, securing a monthly purchase of US$147,000 worth of products aimed at oncology patients. The agreement, stemming from a process of six months involving product review and regulatory clearance, highlights Allied's entry into the Brazilian medical market. The hospital involved, recognized as one of the world's best, will utilize Allied's products for complex oncology and neurology care, potentially enhancing the company's growth and shareholder value.